The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer

被引：32
|
作者：
Partin, AW [1 ]
Carter, HB [1 ]
机构：
[1] JOHNS HOPKINS MED INST, BRADY UROL INST, DEPT UROL, BALTIMORE, MD 21205 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 1996年 / 23卷 / 04期
关键词：
D O I：
10.1016/S0094-0143(05)70333-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Although there is controversy regarding the benefit of early detection of prostate cancer, it has been demonstrated that early detection can be best achieved through the use of a combination of digital rectal examination and prostate-specific antigen (PSA). This article outlines the clinical use of PSA for early detection of prostate cancer and focuses primarily on the value of molecular forms of PSA (free PSA, complexed PSA, and total PSA) in the diagnosis of localized prostate cancer.
引用
收藏
页码：531 / +
页数：1
相关论文
共 50 条
  • [1] Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen
    vanIersel, MP
    Witjes, WPJ
    Thomas, CMG
    Segers, MFG
    Oosterhof, GON
    Debruyne, FMJ
    [J]. PROSTATE, 1996, : 48 - 57
  • [2] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    [J]. ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6
  • [3] Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer
    Chen, YT
    Luderer, AA
    Thiel, RP
    Carlson, G
    Cuny, CL
    Soriano, TE
    [J]. UROLOGY, 1996, 47 (04) : 518 - 524
  • [4] Utility of total prostate-specific antigen and free prostate-specific antigen index to detect prostate cancer in the asymptomatic patient
    Rivera-Sanchez, Roberto
    Parre-Mendez, Carlos
    Luisa Caballero-Juradoc, Maria
    Flores-Paz, Rocio
    [J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2022, 56 (01): : 11 - 15
  • [5] The role of free prostate-specific antigen in the diagnosis of prostate cancer
    Akdas, A
    Cevik, I
    Tarcan, T
    Turkeri, L
    Dalaman, G
    Emerk, K
    [J]. BRITISH JOURNAL OF UROLOGY, 1997, 79 (06): : 920 - 923
  • [6] Serum free prostate-specific antigen in the diagnosis of prostate cancer
    Leung, HY
    Lai, LC
    Day, J
    Thomson, J
    Neal, DE
    Hamdy, FC
    [J]. BRITISH JOURNAL OF UROLOGY, 1997, 80 (02): : 256 - 259
  • [7] Variation of free and total prostate-specific antigen levels - The effect on the percent free/total prostate-specific antigen
    Nixon, RG
    Lilly, JD
    Liedtke, RJ
    Batjer, JD
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1997, 121 (04) : 385 - 391
  • [8] Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher T.
    [J]. CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1230 - 1234
  • [9] Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate
    Wolff, JM
    Boeckmann, W
    Effert, PJ
    Handt, S
    Jakse, G
    [J]. EUROPEAN UROLOGY, 1996, 30 (04) : 451 - 457
  • [10] Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen
    Morgan, TO
    McLeod, DG
    Leifer, ES
    Murphy, GP
    Moul, JW
    [J]. UROLOGY, 1996, 48 (6A) : 76 - 80
12345